Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Rademaker, Miriam T ^a   Cameron, Vicky A ^a   Charles, Christopher J ^a   Espiner, Eric A ^a   Nicholls, M Gary ^a   Pemberton, Christopher J ^a   Richards, A Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cardiac dysfunction; Endothelin; Myocardial infarction; Natriuretic peptides; Remodeling; Renin angiotensin system

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; ENDOTHELIN; NATRIURETIC FACTOR; RENIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HORMONAL REGULATION; NEUROENDOCRINOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHEEP;

EID: 0034102217     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.3.h731     Document Type: Article

References (41)

1. Arakawa, N., M. Nakamura, H. Aoki, and K. Hiramori. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 85: 334-340, 1994.
2. Arakawa, N., M. Nakamura, H. Aoki, and K. Hiramori. Plasma brain natriuretic peptide concentrations predict survival after myocardial infarction. J. Am. Coll. Cardiol. 27: 1656-1661, 1996.
3. Ba'albaki, H. A., and S. D. Clements. Left ventricular aneurysm: a review. Clin. Cardiol. 12: 5-13, 1989.
4. Benedict, C. R., and D. G. Grahame-Smith. Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock. Br. Heart J. 42: 214-220, 1979.
5. Cleland, J. G. F., P. J. Cowburn, and K. Morgan. Neuroendocrine activation after myocardial infarction: causes and consequences. Heart 76: 53-59, 1996.
6. Cody, R. J., G. J. Haas, P. F. Blinkey, Q. Capers, and R. Kelley. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85: 504-509, 1992.
7. Dunn, P. J., and E. A. Espiner. Outpatient screening tests for primary aldosteronism. Aust. NZ J. Med. 6:131-135, 1976.
8. Eaton, W. E., and B. H. Buckley. Expansion of acute myocardial infarction: its relationship to infarct morphology in a canine model. Circ. Res. 49: 80-88, 1981.
9. Espiner, E. A., A. M. Richards, T. G. Yandle, and M. G. Nicholls. Natriuretic hormones. Endocrinol. Metab. Clin. N. Am. 24: 481-509, 1995.
10. Fitzpatrick, M. A., M. G. Nicholls, E. A. Espiner, H. Ikram, T. G. Yandle, P. Bagshaw, G. Collyer, and G. A'Court. Neurohumoral changes during the onset and offset of ovine heart failure: role of ANP. Am. J. Physiol. Heart Circ. Physiol. 256: H1052-H1059, 1989.
11. Foy, S. G., I. G. Crozier, A. M. Richards, M. G. Nicholls, J. G. Turner, C. M. Frampton, and H. Ikram. Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition. Eur. Heart J. 16: 770-778, 1995.
12. Goldstein, D. S., G. Feuerstein, J. L. Izzo, I. J. Kopin, and H. R. Keiser. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci. 28: 267-275, 1981.
13. Hu, R. M., E. R. Levin, A. Pedram, and H. J. L. Frank. Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells: mediation through the C-receptor. J. Biol. Chem. 267: 17384-17389, 1992.
14. Hunt, P. J., A. M. Richards, M. G. Nicholls, T. G. Yandle, R. N. Doughty, and E. A. Espiner. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin. Endocrinol. 47: 287-296, 1997.
15. Hunt, P. J., T. G. Yandle, M. G. Nicholls, A. M. Richards, and E. A. Espiner. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma Biochem. Biophys. Res. Commun. 214: 1175-1183, 1995.
16. Jones, S. M., M. S. Kirby, S. E. Harding, G. Vescova, R. B. Wanless, L. D. Dalla Libera, and P. A. Poole-Wilson. Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte function. Cardiovasc. Res. 24: 834-842, 1990.
17. Kinnunen, P., O. Vuolteenaho, and H. Ruskoaho. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 132: 1961-1970, 1993.
18. Kohno, M., K. Yasunari, K. Yokokawa, K. Murakawa, T. Horio, and T. Takeda. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J. Clin. Invest. 87: 1999-2004, 1991.
19. Lee, M. E., W. L. Miller, and J. C. Burnett, Jr. Role of endogenous atrial natriuretic factor in acute congestive heart failure. J. Clin. Invest. 84: 1962-1966, 1989.
20. Lohmeier, T. E., H. L. Mizelle, G. A. Reinhart, J. P. Montani, C. E. Hord, and R. H. Didlake. Atrial natriuretic peptide and sodium homeostasis in compensated heart failure. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 271: R1353-R1363, 1996.
21. Luchner, A., T. L. Stevens, D. D. Borgeson, M. Redfield, C. M. Wei, J. G. Porter, and J. C. Burnett. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am. J. Physiol. Heart Circ. Physiol. 274: H1684-H1689, 1998.
22. Markovitz, L. J., E. B. Savage, M. B. Ratcliffe, J. E. Bavaria, G. Kreiner, R. V. Iozzo, W. C. Hargrove III, D. K. Bogen, and L. H. Edmunds. Large animal model of left ventricular aneurysm. Ann. Thorac. Surg. 48: 838-845.
23. Millner, R. W. J., J. M. Mann, I. Pearson, and J. R. Pepper. Experimental model of left ventricular failure. Ann. Thorac. Surg. 52: 78-83, 1991.
24. Motwani, J. G., H. McAlpine, N. Kennedy, and A. D. Struthers. Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibitor after myocardial infarction. Lancet 341: 1109-1113, 1993.
25. Mukoyama, M., K. Nakao, K. Hosoda, S. Suga, Y. Saito, Y. Ogawa, G. Shirakami, M. Jougasaki, K. Obata, H. Yasue, Y. Kambayashi, K. Inouye, and H. Imura. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87: 1402-1412, 1991.
26. Muller-Bardorff, M., K. Hallermayer, A. Schroder, C. Ebert, A. Borgya, W. Gerhardt, A. Remppis, J. Zehelein, and H. A. Katus. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin. Chem. 43:458-466, 1997.
27. Nadeau, R. A., and J. de Champlain. Plasma catecholamines in acute myocardial infarction. Am. Heart J. 98: 548-54, 1979.
28. Nagaya, N., T. Nishikimi, Y. Goto, Y. Miyao, Y. Kobayashi, I. Morii, S. Daikoku, T. Matsumoto, S. Miyazaki, H. Matsuoka, S. Takishita, K. Kangawa, H. Matsuo, and H. Nonogi. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocarial infarction. Am. Heart J. 135: 21-28, 1998.
29. Omland, T., R. T. Lie, A. Aakvaag, T. Aarsland, and K. Dickstein. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89: 1573-1579, 1994.
30. Pemberton, C. J., T. G. Yandle, C. J. Charles, M. T. Rademaker, G. D. Aitken, and E. A. Espiner. Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular form. J. Endocrinol. 55: 541-550, 1997.
31. Pemberton, C. J., T. G. Yandle, M. T. Rademaker, C. J. Charles, G. D. Aitken, and E. A. Espiner. Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload. Am. J. Physiol. Heart Circ. Physiol. 275: H1200-H1208, 1998.
32. Pfeffer, M. A., J. M. Pfeffer, C. Steinberg, and P. Finn. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72: 406-412, 1985.
33. Richards, A. M., M. G. Nicholls, T. G. Yandle, C. Frampton, E. A. Espiner, J. G. Turner, R. C. Buttimore, J. G. Lainchbury, J. M. Elliott, H. Ikram, I. G. Crozier, and D. W. Smyth. Plasma N-terminal pro-brain-natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97: 1921-1929, 1998.
34. Rona, G., C. I. Chappel, T. Balazs, and R. Gaudry. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch. Pathol. 67: 443-455, 1959.
35. Sharpe, N., H. Smith, J. Murphy, and S. Hannan. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1: 255-259, 1988.
36. Shimoike, H., N. Iwai, and M. Kinoshita. Differential regulation of natriuretic peptide genes in infarcted rat hearts. Clin. Exp. Pharmacol. Physiol. 24: 23-30, 1997.
37. Sumida, H., H. Yasue, M. Yoshimura, K. Okumura, H. Ogawa, K. Kugiyama, K. Matsuyama, E. Morita, and K. Nakao. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J. Am. Coll. Cardiol. 25: 1105-1110, 1995.
38. Szasz, G., W. Gruber, and E. Bernt. Creatin kinase in serum: determination of optimum reaction conditions. Clin. Chem. 22: 650-656, 1976.
39. Vaughan, D. E., and M. A. Pfeffer. Postmyocardial infarction ventricular remodelling: animal and human studies (Review). Cardiovasc. Drugs Ther. 8: 453-460, 1994.
40. Wei, C. M., A. Lerman, R. J. Rodeheffer, C. G. A. McGregor, R. R. Brandt, S. Wright, D. M. Heublein, W. D. Edwards, and J. C. Burnett. Endothelin in human congestive heart failure. Circulation 89: 1580-1586, 1994.
41. Yandle, T. G., D. L. Vesely, P. J. Hunt, E. A. Espiner, A. M. Richards, M. G. Nicholls, and M. Sage. Intracellular forms of BNP in humans: evidence for amino terminal BNP formation from proBNP prior to secretion (Abstract). Proc. Int. Congr. Endocrinol. San Francisco, CA 1996, p. 757.